Realize safe, scalable, and compliant cell therapies by building analytical strategies that exceed regulatory expectations.

Utilities, federal agencies, and the national labs have finally assembled the tools to harden the grid against an ...

Four competing technologies race to solve radiation therapy's 2.5% range problem. Deep dive into radiacoustic imaging, prompt ...

NVIDIA’s Tim Costa on how AI tools can transform the way manufacturers design, simulate and build products, from chip ...

Researchers have split autism into two distinct biological subtypes, one defined by reduced neuronal connectivity and ...

The following is a detailed human rights assessment of the text of the bilateral health Memoranda of Understanding between ...

Before turning to the quarter, I'd like to begin by recapping the Q1 announcements we highlighted on our last earnings call.

Significant institutional momentum around large-format additive manufacturing and the push for faster production in U.S.

The BMW M3 has held a coveted position in the automotive hierarchy for over three decades. This is no longer a story told in ...

Discover how NASA's hurricane hunter and college students are revolutionizing urban atmospheric research over Houston's skies ...

Background To evaluate the efficacy and safety of aflibercept biosimilars compared with reference aflibercept in the treatment of neovascular age-related macular degeneration (nAMD). Methods A ...